Pay in 4 interest-free payments of $5.93 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
Immunogenicity: No Antibody Formation A critical safety consideration for any peptide therapy is immunogenicity, the potential to trigger immune system responses that could lead to allergic reactions, reduced efficacy through antibody neutralization, or autoimmune complications
Within that metabolic field 5-Amino-1MQ occupies a distinct place: it is not a peptide, but a small research molecule described in research models as an inhibitor of the enzyme NNMT, which makes it of interest within NAD+ focused metabolic research
We invite you to [Explore High-Purity Research Peptides] on our site and discover the exceptional quality and support we offer
We are conveniently located at 8095 Roswell Road, Suite A, Sandy Springs, GA 30350
Preclinical research summary Preclinical investigations have evaluated AOD9604 in obese murine models and in 3-adrenergic receptor knockout mice, using lipid metabolism and body composition endpoints to support mechanistic hypotheses regarding adipose biology
